e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Lung cancer biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical significance of hypoxia inducible factor-1α and VEGF expression in lung cancer
E. Karetsi, T. Kerenidi, M. Ioannou, G. Koukoulis, K. Gourgoulianis, P. A. Molyvdas, E. Paraskeva (Larissa, Greece)
Source:
Annual Congress 2009 - Lung cancer biology
Session:
Lung cancer biology
Session type:
E-Communication Session
Number:
283
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Karetsi, T. Kerenidi, M. Ioannou, G. Koukoulis, K. Gourgoulianis, P. A. Molyvdas, E. Paraskeva (Larissa, Greece). Clinical significance of hypoxia inducible factor-1α and VEGF expression in lung cancer. Eur Respir J 2009; 34: Suppl. 53, 283
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Clinical significance of serum survivin, MGB-1 and Pref-1 levels during chemotherapy of lung cancer
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Clinical significance of serum osteopontin levels in lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Prognostic significance of serum vascular endothelial growth factor and angiopoietin-2 in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
EGFR
and
hTERT
mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Prognostic significance of the expressions of Axl and/or Gas6 in patients with completely resected lung adenocarcinoma
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
The clinical significance of soluble E-cadherin in lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 769s
Year: 2006
Prognostic significance of epidermal growth factor receptor expression in nonsmall cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 72s
Year: 2002
Distribution of BCL-2 gene expression and its prognostic value in non-small cell pulmonary cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 72s
Year: 2002
Increased vascular-endothelial growth factor a (VEGF-A) expression and response to angiogenesis inhibitor erlotinib in non-small-cell lung cancer (NSCLC) – hint for a new predictive marker?
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007
Expression of vascular endothelial-cadherin and vascular endothelial growth factor in non-small cell lung cancer and their clinical significances
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Adenovirus-mediated AP-2α down-regulates MnSOD expression in lung cancer A549 cells and its molecular mechanism
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
The effects of hypoxia on the expression of MMP-2, MMP-9 in human lung adenocarcinoma A549 cells
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
Prognostic value of p21 protein expression in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 674s
Year: 2004
Hypoxia inducible factor-1 alpha (HIF-1 alpha) expression was correlated with the survival in patients with small cell lung cancer (SCLC)
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
The effect of SDF-1/CXCR4 on expression of VEGF and MMP-9 in small cell lung cancer
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Clinical evaluation of the plasma levels of hTERT and EGFR expression as markers for early detection of non-small cell lung cancer
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009
microRNA-34a and microRNA 199a-5p in COPD and their control of HIF-1α expression in pulmonary vasucular endothelial cells
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Prognostic significance of MUC1 expression in resected lung adenocarcinoma
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept